Endocrinology, Vol 130, 1231-1237, Copyright © 1992 by Endocrine Society

ARTICLES

Effects of thyroid hormones on angiotensinogen gene expression in rat liver, brain, and cultured cells

LQ Hong-Brown and CF Deschepper
Department of Physiology, University of California, San Francisco 94143- 0444.

We examined the effect of chronic hypo- and hyper- thyroidism on angiotensinogen (AOG) gene expression in rat liver and brain. Chronic hypothyroidism resulted in approximately a 50% decrease in plasma AOG and AOG messenger RNA (mRNA) concentrations in liver, diencephalon, and brain stem. In contrast, plasma AOG and liver AOG mRNA concentrations were elevated by about 75% during hyperthyroidism, but no change was seen in diencephalon and brain stem. In vitro, the effect of T3 on AOG secretion by rat hepatoma cell lines H35 and H4IIEC-3 depended on the type of cell line used and on the growth status of the cells. At confluency, H35 cells were more responsive to T3 than H4IIEC-3 cells. In addition, subconfluent H35 cells were less responsive to T3 than confluent ones, although no difference was observed in the number of nuclear T3 binding sites or in the responsiveness to dexamethasone. T3 also increased AOG mRNA concentration in confluent H35 cells. Finally, AOG secretion by primary cultures of rat astrocytes increased approximately 1.8-fold following exposure to T3. The fact that T3 increased the production of AOG by these various types of cell culture in vitro suggests that it acted directly upon these cells, and that the effect of thyroid hormone was not dependent on the prior stimulation of another hormone. However, the difference in responsiveness between confluent and subconfluent H35 cells indicates that the action of thyroid hormones may be dependent on the induction of secondary genes within these cells.

This article has been cited by other articles:

				R. C. Speth, M. S. Smith, and K. L. Grove Lactation decreases angiotensinogen mRNA expression in the midcaudal arcuate nucleus of the rat brain Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2001; 280(4): R1169 - R1176. [Abstract] [Full Text] [PDF]

				S. Masciotra, S. Picard, and C. F. Deschepper Cosegregation Analysis in Genetic Crosses Suggests a Protective Role for Atrial Natriuretic Factor Against Ventricular Hypertrophy Circ. Res., June 25, 1999; 84(12): 1453 - 1458. [Abstract] [Full Text] [PDF]

				T. Ishigami, S. Umemura, K. Tamura, K. Hibi, N. Nyui, M. Kihara, M. Yabana, Y. Watanabe, Y. Sumida, T. Nagahara, et al. Essential Hypertension and 5' Upstream Core Promoter Region of Human Angiotensinogen Gene Hypertension, December 1, 1997; 30(6): 1325 - 1330. [Abstract] [Full Text]

				A. R. Brasier, J. Li, and K. A. Wimbish Tumor Necrosis Factor Activates Angiotensinogen Gene Expression by the Rel A Transactivator Hypertension, April 1, 1996; 27(4): 1009 - 1017. [Abstract] [Full Text]

				A. R. Brasier and J. Li Mechanisms for Inducible Control of Angiotensinogen Gene Transcription Hypertension, March 1, 1996; 27(3): 465 - 475. [Abstract] [Full Text]